İlko İlaç

İlko İlaç is a prominent Turkish pharmaceutical company dedicated to the research, development, and manufacturing of a broad range of generic and value-added medicines. Founded by the Öncel family under Selçuklu Holding, the company operates a state-of-the-art manufacturing facility in Konya and a dedicated R&D center, İlko Argem, in Istanbul. Their portfolio spans multiple therapeutic areas including oncology, cardiology, and central nervous system disorders. A key strategic focus for the company is its investment in biotechnology through the İlko Argem Biotechnology Center, which aims to develop biosimilars and innovative biotechnological products. İlko İlaç serves both domestic and international markets, emphasizing high-quality production standards and global expansion through strategic partnerships.